news

Clinical research of traditional Chinese medicine, maximizing the application of traditional Chinese medicine pharmacology... after deep integration with cutting-edge technologies such as digitalization, big data, and science and technology, the development path of traditional Chinese medicine has been continuously broadened, allowing the energy of traditional Chinese medicine to radiate to more scenarios.

What kind of vitality and innovation can traditional Chinese medicine pharmacology, Chinese patent medicine and "new quality productivity" collide with? Enter Beijing Tong Ren Tang Co., Ltd. (hereinafter referred to as "Tong Ren Tang Co., Ltd.") and let us jointly reveal the process of Chinese patent medicine from tradition to digitalization and the research on new functions of classic products.

Traditional Chinese medicine takes the digital express train

How to cultivate and develop new quality productivity is still a difficult problem that all industries need to answer first. The starting point of new quality productivity is "new". Time-honored brands with a long history and profound heritage also need to leverage new tools.

Policy dividends supporting traditional Chinese medicine are emerging frequently, and the industry is also in a golden opportunity period. In Tong Ren Tang Co., Ltd., the combination of digitalization and AI continues to deepen and empower the main business. According to Zhang Chaohua, deputy secretary of the Party Committee and general manager of Beijing Tong Ren Tang Co., Ltd., digital technology and AI have also been absorbed into Tong Ren Tang Co., Ltd.'s boutique strategy.

In the practice of digitalization, Tong Ren Tang Co., Ltd. has drawn up a digital treasure book. Zhang Chaohua said that Tong Ren Tang's knowledge graph system of traditional Chinese medicine uses AI technology to build a database with Tong Ren Tang's key drugs as the core, which contains more than 20,000 related knowledge nodes such as the properties, ingredients, functions, specifications, properties, and clinical applications of more than 100 products. Tong Ren Tang Co., Ltd. uses a combination of offline and online applications for graph retrieval, intelligent answering, and virtual venue services, and can answer questions and resolve doubts by touching the "cloud manual" with your fingertips. The traditional Chinese medicine knowledge graph system also obtained the "Computer Software Copyright Registration Certificate" issued by the National Copyright Administration in 2023.

In addition to the integration and presentation of prescriptions, Tong Ren Tang Co., Ltd. combines traditional pharmaceutical techniques with industrialized production in production, increases the upgrading and transformation of intelligent related technologies, and establishes digital production workshops. Zhang Chaohua said that the company's Daxing production base has added a 9-gram line intelligent manufacturing project, and completed the online trial production of pill making, pill drying, wax dipping, and outsourcing processes for trial products, which also "continues the momentum" of Tong Ren Tang Co., Ltd.'s production capacity.

It is reported that Tong Ren Tang Co., Ltd. uses professional databases and supply chain systems to conduct online digital intelligent management and offline production mode interconnection, realize smart production scheduling, and further improve production efficiency. In order to accelerate the promotion of informatization construction and gradually realize the deep integration of informatization and the traditional Chinese medicine industry, we will cooperate in the construction of the supply chain operation platform.

Digital penetration starts from point to surface. The first phase of Tong Ren Tang Co., Ltd.'s digital supply chain project has achieved remarkable results. At present, the development and implementation of functional modules such as supplier management, procurement process optimization, and finished product output have been realized. While optimizing the information sharing and collaborative working capabilities of each link in the supply chain, the sophistication and accuracy of production process management have been greatly improved. In order to ensure the smooth acceptance of the project, a detailed verification report was written to evaluate and summarize the completion of the project. Through multiple internal training and drills, the acceptance process was ensured to proceed smoothly.

Zhang Chaohua said that while leveraging the power of data to innovate and empower, Tong Ren Tang Co., Ltd. is still inheriting and carrying forward the traditional manual pill-making process, striving to find a balance between brand historical heritage and modern industrial production, and deepening industrial application scenarios. In the future, the company will continue to deepen reforms, improve service quality and efficiency, and ensure continuous improvement of operational efficiency and management sophistication.

Explore pharmacology and efficacy to serve modern lifestyle

When it comes to Tong Ren Tang, the inheritance of generations is its history and trademark, and the mission of the times given to the time-honored brand is to remain fresh over time. The new usage of classic products has become a new attempt for the time-honored brand to expand the market and get closer to consumers.

As consumers' demands for health become higher and more diversified, Tong Ren Tang Co., Ltd. has explored the pharmacology and efficacy of traditional Chinese medicine, allowing traditional medicines to have more application scenarios. For example, the well-known Yishen Qiangshen Pills and Fangsui Yishou Pills are a pair of prescriptions for prolonging life and resisting aging. The efficacy of the medicine in improving immunity, improving memory, improving sexual function, resisting fatigue, resisting hypoxia, and improving sleep has been continuously demonstrated.

According to researchers' recollections, as early as the 1980s, before and after the launch of Yishen Qiangshen Pills and Fangsui Yishou Pills, many medical institutions conducted a series of studies such as clinical verification and mechanism exploration. In 1987, the news of Shi Jinmo's anti-aging medicine attracted the attention of Professor Dai Yaoren of the Department of Biology of Peking University. Based on the experimental results, he published an academic paper entitled "The Effect of Shi Jinmo's Anti-Aging Recipe Preparation on the Activity of Type B Monoamine Oxidase in Mouse Brain and Liver and the Lifespan of Drosophila". Since 2018, the company has carried out clinical and pharmacological and pharmacodynamic studies on the kidney-tonifying and anti-aging effects with Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Beijing University of Chinese Medicine and other units, and designed a complete set of scientific research plans, and published relevant papers based on the research results. In the future, Tongrentang Co., Ltd. will continue to increase related research to allow classic prescriptions to serve the health cause of the whole people.

The exploration of the efficacy and pharmacology of Yishen Qiangshen Pills and Fangsui Yishou Pills is a microcosm of Tongrentang Co., Ltd.'s continuous deepening of the secondary development of core drugs. The secondary development of key products such as Angong Niuhuang Pills and Tongren Niuhuang Qingxin Pills is carried out to explore potential varieties, explore the value of varieties, enrich varieties, and enhance market competitiveness.

Taking Tongren Niuhuang Qingxin Pills, one of the "Tongren Series Three Pills", as an example, the public's traditional perception of Tongren Niuhuang Qingxin Pills is that it is mainly used to treat chronic cerebral ischemia vertigo, precursors to stroke (TIA), hypertension, etc. According to the latest pharmaceutical research, this drug can relieve anxiety, insomnia, and reduce body damage.

It is worth mentioning that the Quality Inspection Department of Tong Ren Tang Co., Ltd.'s Daxing Production Base has obtained the laboratory accreditation certificate issued by the China National Accreditation Service for Conformity Assessment (CNAS), which not only ensures the quality and efficacy, but also expands the company's competitiveness and influence in domestic and foreign markets.

Whether it is new product development or the re-exploration of key varieties, traditional Chinese medicine is constantly adapting to the market. Today, Tong Ren Tang Co., Ltd. produces more than 400 Chinese patent medicines all year round, with a wide range of product dosage forms, including pills, powders, wine preparations, capsules, oral liquids, and drip pills, etc. More than 20 product dosage forms.

Fine management accumulates energy for high-quality development

Statistics show that the market size of my country's traditional Chinese medicine industry has reached 1,669.69 billion yuan in 2021. It is expected that the traditional Chinese medicine industry will continue to expand at a compound annual growth rate of 6.93%, and the market size will exceed 2.1 trillion yuan by 2025, reaching 2,182.66 billion yuan. While the market of more than 2 trillion yuan provides broad development space for traditional Chinese medicine companies including Tongrentang Co., Ltd., industry competition is also intensifying.

Inheriting the essence, adhering to the right path and innovating, the time-honored brand has opened a new chapter. Tong Ren Tang Co., Ltd. has consolidated and reshaped its brand image through digitalization and e-commerce marketing; through innovation and scientific research investment, it has continuously explored existing varieties, and refined management to improve product quality and create service value.

Data shows that Tong Ren Tang Co., Ltd. continues to increase terminal investment and increase sales. It classifies varieties, optimizes resource allocation, gives full play to the advantages of internal and external platforms, direct supply terminals, and distribution of special varieties, and increases the layout and promotion of retail terminals. Online, it integrates multi-platform resources of e-commerce networks, and effectively expands product exposure channels by using festivals, solar terms, theme activities, etc.; opens up a new marketing and operation path for the Imperial Medicine Legend series, adheres to the principle of refined dealer access and terminal store selection, and customizes a sales model that meets the product positioning; optimizes the marketing system and enhances market vitality.

Zhang Chaohua mentioned that in 2024, the company will continue to promote the implementation of the large-variety strategy, give play to the demonstration effect of advantageous varieties, and promote the sales of large varieties; continue to promote the implementation of the boutique strategy, accelerate the creation of a new product marketing system, and use publicity and promotion potential to drive market sales momentum; give play to core competitiveness such as brand, variety, quality, and capital, and through investment, make up for shortcomings and expand scale, promote the layout of the entire industrial chain from breeding, research and development, production and manufacturing to wholesale and retail, and continuously enhance the company's core competitiveness.